|
Published in the
Bulletin of Experimental Treatments for AIDS December 1996 issue,
by the San Francisco AIDS Foundation.
December
1996 Table of Contents
Main Page
beta@sfaf.org
|
|
Drugs Covered by the California
AIDS Drug Assistance Program
The California AIDS Drug Assistance Program (ADAP) was established in
October 1987 to provide drugs to individuals who otherwise could not afford
them. The drugs provided by ADAP have been determined to prolong quality
of life and to prevent the deterioration of health among individuals infected
with HIV.
An ADAP Advisory Committee consisting of physicians and community members
was established in 1991. The committee meets as needed to review the ADAP
formulary, to evaluate available HIV/AIDS drugs and to make recommendations
for changes to the formulary.
Individuals are eligible for ADAP if: 1) they have an adjusted gross
income below $50,000 per year; 2) they have a valid prescription from
a California-licensed physician; and 3) the drugs they need are not covered
by Medi-Cal or another third-party payer. An individual is subject to
a co-payment if his/her annual adjusted gross income is between 400% of
the poverty level and $50,000. Individuals with an annual adjusted gross
income below 400% of the poverty level receive the drugs for free.
ADAP is administered by local health jurisdictions. These jurisdictions
are required to collect and report specific demographic data on the clients
enrolled in their program (e.g., date of birth, gender, diagnosis, drugs
received). The data are used to monitor the program and to identify trends.
For more information about ADAP and referrals to local offices,
call the California Office of AIDS at 916-327-6784. In San Francisco,
call the Department of Public Health AIDS Office at 415-554-9000. Many
states have similar drug assistance programs.
List of covered
drugs
3TC (lamivudine, Epivir) -- HIV infection
acyclovir (Zovirax) -- herpes simplex, herpes zoster
alpha interferon (Intron-A, Roferon-A) -- Kaposi's sarcoma, anogenital
neoplasms
amphotericin B (Fungizone) -- fungal infections
atovaquone (Mepron) -- Pneumocystis carinii pneumonia (PCP)
azithromycin (Zithromax) -- toxoplasmosis, complex
Mycobacterium avium AZT (zidovudine, Retrovir) -- HIV infection
bleomycin sulfate (Blenoxane) -- Kaposi's sarcoma, lymphoma
clarithromycin (Biaxin) -- MAC
clindamycin HCL (Cleocin) -- toxoplasmosis, PCP
clofazimine (Lamprene) -- MAC
clotrimazole (Lotrimin, Mycelex) -- fungal infections
cyclophosphamide (Cytoxan) -- lymphoma, cancer
d4T (stavudine, Zerit) -- HIV infection
dapsone -- PCP
ddC (zalcitabine, Hivid) -- HIV infection
ddI (didanosine, Videx) -- HIV infection
dexamethasone (Decadron, Hexadrol) -- steroid, anti-inflammatory
doxorubicin (Adriamycin) -- Kaposi's sarcoma, cancer
dronabinol (Marinol) -- HIV-related wasting
epoetin alpha (Epogen, Procrit) -- AZT-related anemia
ethambutol (Myambutol) -- MAC, tuberculosis
G-CSF (Filgrastim, Neupogen) -- neutropenia
fluconazole (Diflucan) -- fungal infections
flucytosine (Ancobon) -- fungal infections
foscarnet (Foscavir) -- cytomegalovirus (CMV) disease
ganciclovir (Cytovene) -- CMV disease
indinavir (Crixivan) -- HIV infection
itraconazole (Sporanox) -- fungal infections
ketoconazole (Nizoral) -- fungal infections
leucovorin calcium (Leucovorin) -- anemia
megestrol acetate (Megace) -- HIV-related wasting
methotrexate (Rheumatrex) -- cancer, psoriasis
nystatin (Mycostatin) -- fungal infections
paromomycin (Humatin) -- cryptosporidiosis
pentamidine (Nebupent, Pentam) -- PCP prophylaxis and treatment
prednisone (Deltasone, Prednicen-M, Sterapred) -- anti-inflammatory
pyrimethamine (Daraprim) -- toxoplasmosis
rifabutin (Mycobutin) -- MAC prophylaxis
ritonavir (Norvir) -- HIV infection
saquinavir (Invirase) -- HIV infection
sulfadiazine (Microsulfon) -- toxoplasmosis, cryptococcal meningitis
TMP-SMX (Bactrim, Septra) -- PCP prophylaxis, acute PCP
trimethoprim (Trimpex, Proloprim) -- PCP
trimetrexate glucuronate (NeuTrexin) -- PCP, toxoplasmosis
vinblastine sulfate (Velban) -- Kaposi's sarcoma, lymphoma
vincristine sulfate (Oncovin) -- Kaposi's sarcoma, lymphoma
Page last updated 17 December 1996
|
